Robert Stahelin

Robert Stahelin

Activation and Regulation of Peripheral Proteins


Professor Stahelin received his Ph.D. in chemistry from the University of Illinois-Chicago studying the structural basis of lipid-protein interactions in health and disease.  During postdoctoral work at the University of Illinois-Chicago he investigated the mechanisms with which bioactive lipid signals recruit peripheral proteins in cell signaling and membrane trafficking. Professor Stahelin is an IUSM Showalter Scholar and Associate Professor of Biochemistry and Molecular Biology at the Indiana University School of Medicine-South Bend.  He is also an Adjunct Associate Professor of Chemistry and Biochemistry at Notre Dame.  Since joining the faculty in 2006, Professor Stahelin has received grants from the NIH, NSF, and American Heart Association.  He serves on several journal editorial boards including Chemistry & Physics of Lipids, Current Drug Targets, and Journal of Biomembranes and Bioenergetics.  In 2013 he received an Indiana University Trustees Teaching Award and was named to the Michiana 40 under 40 class.  PhD students from Professor Stahelin’s lab have recently earned American Heart Association Predoctoral Fellowships.

Research Interests

Interdisciplinary research focused on biological membranes has revealed them as signaling and trafficking platforms for processes fundamental to life. Biomembranes harbor receptors, ion channels, lipid domains, lipid signals, and scaffolding complexes, which function to maintain cellular growth, metabolism, and homeostasis. Moreover, abnormalities in lipid metabolism attributed to genetic changes among other causes are often associated with diseases such as cancer, arthritis and diabetes. Thus, there is a need to comprehensively understand molecular events occurring within and on membranes as a means of grasping disease etiology and identifying viable targets for drug development. A rapidly expanding field in the last decade has centered on understanding membrane recruitment of peripheral proteins. This class of proteins reversibly interacts with specific lipids in a spatial and temporal fashion in crucial biological processes. Typically, recruitment of peripheral proteins to the different cellular sites is mediated by one or more modular lipid-binding domains through specific lipid recognition. Structural, computational, and experimental studies of these lipid-binding domains have demonstrated how they specifically recognize their cognate lipids and achieve subcellular localization. However, the mechanisms by which these modular domains and their host proteins are recruited to and interact with various cell membranes often vary drastically due to differences in lipid affinity, specificity, penetration as well as protein-protein and intramolecular interactions. As there is still a paucity of predictive data for peripheral protein function, these enzymes are often rigorously studied to characterize their lipid-dependent properties. Our research is targeted at identifying peripheral protein drug targets, designing predictive functions for this class of proteins, and understanding their biological mechanisms of activation as a means of creating better therapies. The below points highlight the different avenues of research in the Stahelin lab:

  1. Molecular Basis of Viral Assembly. We are investigating how viruses such as the Ebola virus assembles at the plasma membrane of human cells to form the bud site for generation of a new viral particle.  Funded by NIAID.
  2. Discovery of New Lipid-Binding Domains. Integration of computational biology, bioinformatics, structural biology, biochemistry, biophysics, and cell biology to discover new lipid-binding domains in the human genome.
  3. Lipid-Mediated Regulation of Proinflammatory Enzymes. We are elucidating the role of phosphoinositides and sphingolipids in the regulation of proinflammatory enzymes. Funded by the AHA.

Recent Papers

  • Johnson, K.A.; Taghon, G.J.; Scott, J.L.; Stahelin, R.V. "The Ebola Virus matrix protein, VP40, requires phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) for extensive oligomerization at the plasma membrane and viral egress." Sci. Rep. 2016, 6, 19125.
  • Wijesinghe, K.J.; Stahelin, R.V. "Investigation of the Lipid Binding Properties of the Marburg Virus Matrix Protein VP40." J. Virol. 2016, 90, 3074-3085.
  • Del Vecchio, K.; Stahelin, R.V. "Using Surface Plasmon Resonance to Quantitatively Assess Lipid-Protein Interactions." Methods Mol. Biol. 2016, 1376, 141-153.
  • Adu-Gyamfi, E.; Johnson, K.A.; Fraser, M.E.; Scott, J.L.; Soni, S.P.; Jones, K.R.; Digman, M.A.; Gratton, E.; Tessier, C.R.; Stahelin, R.V. "Host Cell Plasma Membrance Phosphatidylserine Regulates the Assembly of Budding Ebola Virus." J. Virol. 2015, 89, 9440-9453.
  • Soni, S.P.; Stahelin, R.V. "The Ebola virus matrix protein VP40 selectively induces vesiculation from phosphatidylserine-enriched membranes." J. Biol. Chem. 2014, 289, 33590-33597.
  • Stahelin, R.V. "Membrane binding and bending in Ebola VP40 assembly and egress." Front. Microbiol. 2014, 5, 300.



View Rob Stahelin's PubMed publication record. 

Contact Information

Primary Research Areas

Research Specialties